I. Motte , H. Roman , B. Clavier , F. Jumeau , I. Chanavaz-Lacheray , M. Letailleur , B. Darwish , N. Rives
{"title":"In vitro fertilization outcomes after ablation of endometriomas using plasma energy: A retrospective case-control study","authors":"I. Motte , H. Roman , B. Clavier , F. Jumeau , I. Chanavaz-Lacheray , M. Letailleur , B. Darwish , N. Rives","doi":"10.1016/j.gyobfe.2016.08.008","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>Ovarian endometrioma ablation using plasma energy appears to be a valuable alternative to cystectomy, because it could spare underlying ovarian parenchyma resulting in high spontaneous and overall pregnancy rates. After initial postoperative decrease, anti-mullerian hormone (AMH) level progressively increases several months after ablation. The aim of our study was to assess the outcomes of in vitro fertilization (IVF) in women managed for ovarian endometriomas by ablation using plasma energy, when compared to those in women free of endometriosis.</p></div><div><h3>Methods</h3><p>Retrospective preliminary case-control study, enrolling women undergoing IVF or IntraCytoplasmic Sperm Injection (ICSI), from July 2009 to December 2014. Cases were infertile women with previous ovarian endometrioma ablation using plasma energy and were matched by age, AMH level and assisted reproductive technique with controls presumed free of endometriosis. IVF/ICSI response (type of protocol, dose of gonadotrophin, number of oocytes, fertilization rate) and outcomes were compared between the two groups.</p></div><div><h3>Results</h3><p>In all, 37 cases were compared to 74 controls. Age (30.9<!--> <!-->±<!--> <!-->4.4 years vs. 31.7<!--> <!-->±<!--> <!-->4.2 years), AMH level (2.8<!--> <!-->±<!--> <!-->2<!--> <!-->ng/mL vs. 2.8<!--> <!-->±<!--> <!-->1.7<!--> <!-->ng/mL) and ART procedures (ICSI in 24.3% vs. 27%) were comparable between the two groups. Of the 37 cases, previous surgical procedures on right and left ovaries were performed in 27% and 21.6% of patients respectively, 81% of patients were nullipara. AFSr score was 73<!--> <!-->±<!--> <!-->41, while deep endometriosis infiltrated the rectum and the sigmoid colon in respectively 40.5% and 27% of patients. Despite a lower number of oocytes retrieved, cases presented better implantation rate, pregnancy and delivery rates per cycle, oocyte retrieval, transfer, and embryo, as well as superior cumulative birth rate per transfer.</p></div><div><h3>Conclusion</h3><p>Ovarian endometrioma ablation using plasma energy is followed by good IVF/ICSI outcomes, suggesting that surgical procedure spares underlying ovarian parenchyma. These results consolidate those of previous studies reporting high spontaneous conception rate. Hence, ovarian endometrioma ablation using plasma energy appears to be a valuable alternative to cystectomy in patients presenting with endometriosis and pregnancy intention.</p></div>","PeriodicalId":55077,"journal":{"name":"Gynecologie Obstetrique & Fertilite","volume":"44 10","pages":"Pages 541-547"},"PeriodicalIF":0.0000,"publicationDate":"2016-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gyobfe.2016.08.008","citationCount":"16","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gynecologie Obstetrique & Fertilite","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1297958916302168","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 16
Abstract
Objective
Ovarian endometrioma ablation using plasma energy appears to be a valuable alternative to cystectomy, because it could spare underlying ovarian parenchyma resulting in high spontaneous and overall pregnancy rates. After initial postoperative decrease, anti-mullerian hormone (AMH) level progressively increases several months after ablation. The aim of our study was to assess the outcomes of in vitro fertilization (IVF) in women managed for ovarian endometriomas by ablation using plasma energy, when compared to those in women free of endometriosis.
Methods
Retrospective preliminary case-control study, enrolling women undergoing IVF or IntraCytoplasmic Sperm Injection (ICSI), from July 2009 to December 2014. Cases were infertile women with previous ovarian endometrioma ablation using plasma energy and were matched by age, AMH level and assisted reproductive technique with controls presumed free of endometriosis. IVF/ICSI response (type of protocol, dose of gonadotrophin, number of oocytes, fertilization rate) and outcomes were compared between the two groups.
Results
In all, 37 cases were compared to 74 controls. Age (30.9 ± 4.4 years vs. 31.7 ± 4.2 years), AMH level (2.8 ± 2 ng/mL vs. 2.8 ± 1.7 ng/mL) and ART procedures (ICSI in 24.3% vs. 27%) were comparable between the two groups. Of the 37 cases, previous surgical procedures on right and left ovaries were performed in 27% and 21.6% of patients respectively, 81% of patients were nullipara. AFSr score was 73 ± 41, while deep endometriosis infiltrated the rectum and the sigmoid colon in respectively 40.5% and 27% of patients. Despite a lower number of oocytes retrieved, cases presented better implantation rate, pregnancy and delivery rates per cycle, oocyte retrieval, transfer, and embryo, as well as superior cumulative birth rate per transfer.
Conclusion
Ovarian endometrioma ablation using plasma energy is followed by good IVF/ICSI outcomes, suggesting that surgical procedure spares underlying ovarian parenchyma. These results consolidate those of previous studies reporting high spontaneous conception rate. Hence, ovarian endometrioma ablation using plasma energy appears to be a valuable alternative to cystectomy in patients presenting with endometriosis and pregnancy intention.
目的:血浆能量切除卵巢子宫内膜瘤是一种有价值的替代膀胱切除术的方法,因为它可以避免潜在的卵巢实质,从而提高自然妊娠率和总妊娠率。术后最初下降后,抗苗勒管激素(AMH)水平在消融后几个月逐渐升高。本研究的目的是评估通过血浆能量消融治疗卵巢子宫内膜异位症的女性体外受精(IVF)的结果,并将其与无子宫内膜异位症的女性进行比较。方法回顾性初步病例对照研究,纳入2009年7月至2014年12月接受体外受精或卵胞浆内单精子注射(ICSI)的妇女。病例为既往使用血浆能量消融术治疗卵巢子宫内膜异位症的不孕妇女,与年龄、AMH水平和辅助生殖技术相匹配,对照组推定无子宫内膜异位症。比较两组的IVF/ICSI反应(方案类型、促性腺激素剂量、卵母细胞数、受精率)及结果。结果37例,对照组74例。年龄(30.9±4.4岁vs. 31.7±4.2岁)、AMH水平(2.8±2 ng/mL vs. 2.8±1.7 ng/mL)和ART程序(ICSI为24.3% vs. 27%)在两组之间具有可比性。37例患者中,分别有27%和21.6%的患者行过左、右卵巢手术,81%的患者无卵巢。AFSr评分为73±41,深部子宫内膜异位症浸润直肠和乙状结肠的比例分别为40.5%和27%。尽管取出的卵母细胞数量较少,但这些病例的着床率、每个周期的妊娠率和分娩率、卵母细胞取出率、移植率和胚胎率都较高,每次移植的累计出生率也较高。结论血浆能量切除卵巢子宫内膜瘤可获得良好的IVF/ICSI结果,提示手术可保护卵巢底层实质。这些结果巩固了先前报道高自然受孕率的研究。因此,对于有妊娠意向的子宫内膜异位症患者,血浆能量切除卵巢子宫内膜异位症似乎是一种有价值的替代膀胱切除术的方法。